CDMO Serán Bioscience announced "a strategic growth transaction" led by Bain Capital Life Sciences that is worth more than $200 million, with the funds intended to support completion of a new commercial-scale manufacturing facility in Bend, Oregon, where the company is headquartered. According to Serán Bio, the commercial-scale facility, which is expected to be … [Read more...] about Serán Bio gets $200 million investment to support new commercial manufacturing facility
Products and Services
Vectura to be acquired by Phillips Medisize parent Molex
Inhalation CDMO Vectura has been sold to Molex for £150 million up front and up to an additional £148 million in potential payments, the companies have announced. Following the acquisition, Vectura will be operated by Phillips Medisize, which was acquired by Molex in 2016. The sale is expected to close by the end of this year. According to the Vectura Fertin press … [Read more...] about Vectura to be acquired by Phillips Medisize parent Molex
TFF Pharmaceuticals partners with Emory University on mRNA-based antiviral DPI with BARDA funding
TFF Pharmaceuticals announced that it will study the feasibility of formulating Emory University's mRNA-based Cas13a antiviral for the treatment of SARS-CoV-2 and influenza A and B as a dry powder using the company's thin film freezing technology. Funding for the study is provided by the Biomedical Advanced Research and Development Authority (BARDA) as part of its … [Read more...] about TFF Pharmaceuticals partners with Emory University on mRNA-based antiviral DPI with BARDA funding
Aptar Pharma to offer services for development projects based on Pulmotree’s Kolibri nebulizer platform
Aptar Pharma announced that it has signed a development and promotion agreement with Pulmotree related to Pulmotree's Kolibri mesh nebulizer, which it refers to as a non-propellant liquid inhaler (NPLI) platform. The company says that its subsidiaries, including inhalation CRO Nanopharm and human factors specialist Noble, will support Kolibri development projects for … [Read more...] about Aptar Pharma to offer services for development projects based on Pulmotree’s Kolibri nebulizer platform
Bespak joins IPAC
According to Bespak, the company has joined the International Pharmaceutical Aerosol Consortium (IPAC), which is the parent organization of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). Earlier this year, Bespak spun out of Recipharm, which joined IPAC-RS as a member in 2022. Bespak will be represented on the IPAC board … [Read more...] about Bespak joins IPAC
US Precision Medicine and MicroNeb announce agreement for use of nebulizer technology for delivery of inhaled antitumor drug
A Florida-based company called MicroNeb and a privately-held biopharma company called US Precision Medicine (USPM) say that they have signed a memorandum of understanding allowing USPM to use MicroNeb nebulizer technology for delivery of an inhaled cancer drug. The MicroNeb web site currently does not provide images, data, or specific details related to any handheld … [Read more...] about US Precision Medicine and MicroNeb announce agreement for use of nebulizer technology for delivery of inhaled antitumor drug
De Motu Cordis announces expansion of deal with Catalent for services related to development of DMC-IH1 epinephrine DPI
Australian pharma company De Motu Cordis (DMC), which is developing an epinephrine DPI for the treatment of anaphylaxis, announced that it has contracted with Catalent for product assembly, expanding a November 2022 deal with the CDMO that covered formulation and manufacturing. The extension of the deal will provide manufacturing and assembly services through a … [Read more...] about De Motu Cordis announces expansion of deal with Catalent for services related to development of DMC-IH1 epinephrine DPI
Micromeritics to be acquired by Malvern Panalytical
Particle characterization specialist Micromeritics Instrument Corporation is set to be acquired by Spectris subsidiary Malvern Panalytical, the companies have announced. According to Spectris, the deal includes a $630 million payment up front and up to an additional $53 million on the achievement of 2024/25 performance goals. Micromeritics' products include the … [Read more...] about Micromeritics to be acquired by Malvern Panalytical
FDA completes inspection of new Kindeva analytical services facility in Minnesota
CDMO Kindeva Drug Delivery announced the completion of an FDA inspection at the company's new laboratory facility in Woodbury, MN, USA and said that the site will continue with routine cGMP audits in the future. The company announced the opening of the Woodbury facility, home to a new analytical services business unit, in January 2024. According to Kindeva, the FDA … [Read more...] about FDA completes inspection of new Kindeva analytical services facility in Minnesota
MHRA approves Type II variation to the Voke nicotine inhaler marketing authorization
OBG subsidiary Ayrton Saunders announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a Type II variation to the 2014 marketing authorization for the Voke nicotine inhaler, which is approved for general sales as a nicotine replacement therapy. According to the Ayrtons web site, the company "has completely redeveloped the original … [Read more...] about MHRA approves Type II variation to the Voke nicotine inhaler marketing authorization